24. Oktober 2022Published by Paul Wolfrom on 24. Oktober 2022Categories 2022 NewsLimmaTech Enters Exclusive License and Collaboration Agreement with Griffith University to Expand its Vaccine Technology Platform
22. September 2022Published by Paul Wolfrom on 22. September 2022Categories 2022 NewsLimmaTech Biologics will be attending the 2022 VASE Conference in Washington from 29 November through 1 December 2022.Dr Patricia Martin to present
22. September 2022Published by Paul Wolfrom on 22. September 2022Categories 2022 NewsLimmaTech Biologics will be attending the Bactivac Annual Network Meeting 2022 in Kilifi, Kenya from 8 through 10 November 2022.Dr Cristina Alaimo to present
22. September 2022Published by Paul Wolfrom on 22. September 2022Categories 2022 NewsLimmaTech Biologics will be attending the BIO-EUROPE in Leipzig, Germany from 24 through 26 October 2022.
22. September 2022Published by Paul Wolfrom on 22. September 2022Categories 2022 NewsLimmaTech Biologics will be attending the DCVMN Annual General Meeting 2022 in Pune, India from 20 through 22 October 2022.
13. Juli 2022Published by Paul Wolfrom on 13. Juli 2022Categories 2022 NewsLimmaTech Biologics will be attending the World Vaccine Congress Europe 2022 in Barcelona from 11 through 14 October 2022.Dr Michael Kowarik to present
13. Juli 2022Published by Paul Wolfrom on 13. Juli 2022Categories 2022 NewsLimmaTech Biologics will be attending the 22nd International Pathogenic Neisseria Conference in Cape Town from 9 through 14 October 2022.
13. Juli 2022Published by Paul Wolfrom on 13. Juli 2022Categories 2022 NewsLimmaTech Biologics will be attending the 16th Vaccine Congress in Riva del Garda, Italy from 12 through 14 September 2022.
13. Juli 2022Published by Paul Wolfrom on 13. Juli 2022Categories 2022 NewsLimmaTech Biologics will be attending the Biennial Meeting on Microbial Carbohydrates in Naples from 27 through 29 July 2022.